Strafford will be offering a webcast entitled "Drug Substance Patents: FDA Guidance, Protecting Composition-of-Matter Patents, Drafting Solid Form Claims" on October 26, 2017 from 1:00 to 2:30 pm (EDT). Eyal H. Barash of Barash Law and Dr. Steef Boerrigter, Senior Research Investigator, Materials Science, SSCI will examine solid forms, provides specific examples of products in the Orange Book using patents to such forms to provide drug substance protection beyond composition of matter, discuss both patentability and infringement issues related to such patents, and also discuss the recent FDA guidance on co-crystals and implications for patent strategy, outline how solid form claims are drafted, and review lessons from recent cases. The webinar will review the following topics:
• A brief scientific introduction to solid forms
• What are the key patentability issues when preparing solid form patents?
• How are pharmaceutical companies using solid form patents?
• What is different about claiming solid form patents with respect to “organic chemistry” claims in other composition-of-matter patents?
• What impact does the FDA guidance on co-crystals have on patenting composition of matter?
The registration fee for the webcast is $297. Those interested in registering for the webinar, can do so here.
Comments